Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity
- PMID: 20933022
- DOI: 10.1016/j.bbr.2010.09.030
Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity
Abstract
D-amino acid oxidase (DAO), an enzyme that degrades d-serine, has been suggested as a susceptibility factor for schizophrenia. Here we sought to understand more about the behavioral consequence of lacking DAO and the potential therapeutic implication of DAO inhibition by characterizing a mouse strain (ddY/DAO(-)) lacking DAO activity. We found that the mutant mice showed enhanced prepulse inhibition responses (PPI). Intriguingly, DAO-/- mice had increased sensitivity to the PPI-disruptive effect induced by the competitive NMDA antagonist, SDZ 220-581. In the 24-h inhibitory avoidance test, DAO-/- mice were not different from DAO+/+ mice during the recall. In Barnes Maze, we found that DAO-/- mice had a shortened latency to enter the escape tunnel. Interestingly, although these mice were hypoactive when tested in a protected open field, they showed a profound increase of activity on the edge of the unprotected open field of the Barnes Maze even with the escape tunnel removed. This increased edge activity does not appear to be related to a reduced level of anxiety given that there were no significant genotype effects on the measures of anxiety-like behaviors in two standard animal models of anxiety, elevated plus maze and novelty suppressed feeding. Our data suggest that DAO-/- mice might have altered functioning of NMDARs. However, these results provide only modest support for manipulations of DAO activity as a potential therapeutic approach to treat schizophrenia.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia.Mol Cell Neurosci. 2006 Aug;32(4):324-34. doi: 10.1016/j.mcn.2006.05.003. Epub 2006 Jul 13. Mol Cell Neurosci. 2006. PMID: 16843004
-
Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.Pharmacol Biochem Behav. 2009 Feb;91(4):610-20. doi: 10.1016/j.pbb.2008.09.016. Epub 2008 Oct 7. Pharmacol Biochem Behav. 2009. PMID: 18940194
-
Mutant mice and rats lacking D-amino acid oxidase.Chem Biodivers. 2010 Jun;7(6):1450-8. doi: 10.1002/cbdv.200900303. Chem Biodivers. 2010. PMID: 20564563 Review.
-
Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.J Pharmacol Exp Ther. 1999 Feb;288(2):643-52. J Pharmacol Exp Ther. 1999. PMID: 9918570
-
D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.Amino Acids. 2012 Nov;43(5):1811-21. doi: 10.1007/s00726-012-1384-x. Epub 2012 Aug 15. Amino Acids. 2012. PMID: 22892863 Review.
Cited by
-
Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Expert Rev Neurother. 2012 Jul;12(7):785-99. doi: 10.1586/ern.12.60. Expert Rev Neurother. 2012. PMID: 22853787 Free PMC article. Review.
-
Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice.Eur J Neurosci. 2016 Apr;43(7):979-89. doi: 10.1111/ejn.13192. Epub 2016 Mar 23. Eur J Neurosci. 2016. PMID: 26833794 Free PMC article.
-
Protective role of D-amino acid oxidase against Staphylococcus aureus infection.Infect Immun. 2012 Apr;80(4):1546-53. doi: 10.1128/IAI.06214-11. Epub 2012 Jan 23. Infect Immun. 2012. PMID: 22271930 Free PMC article.
-
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption.Eur J Neurosci. 2015 May;41(9):1167-79. doi: 10.1111/ejn.12880. Epub 2015 Mar 27. Eur J Neurosci. 2015. PMID: 25816902 Free PMC article.
-
Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder.Mol Psychiatry. 2022 Sep;27(9):3842-3856. doi: 10.1038/s41380-022-01609-4. Epub 2022 May 11. Mol Psychiatry. 2022. PMID: 35546635
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources